Unknown

Dataset Information

0

Dual inhibition of HDAC and tyrosine kinase signaling pathways with CUDC-907 attenuates TGF?1 induced lung and tumor fibrosis.


ABSTRACT: TGF?1 signaling is a critical driver of collagen accumulation in pulmonary fibrotic diseases and a well-characterized regulator of cancer associated fibroblasts (CAF) activation in lung cancer. Myofibroblasts induced by TGF?1 and other factors are key players in the pathogenesis of lung fibrosis and tumor. Tremendous attention has been gained to targeting myofibroblasts in order to inhibit the progression of fibrosis and myofibroblast-induced tumor progression and metastasis. Here we determined the therapeutic efficacy of simultaneously targeting PI3K and HDAC pathways in lung myofibroblasts and CAF with a single agent and to evaluate biomarkers of treatment response. CUDC-907 is a first-in-class compound, functioning as a dual inhibitor of HDACs and PI3K/AKT pathway. We investigated its effects in counteracting the activity of TGF?1-induced myofibroblasts/CAF in regard to cell proliferation, migration, invasion, apoptosis in vitro antifibrosis efficiency in vivo. We found that CUDC-907 inhibited myofibroblasts/CAF cell proliferation, migration and apoptosis in a dose-dependent manner and caused cell cycle arrest at G1-S phase. CUDC-907 not only inhibited myofibroblasts markers expression, but also significantly inhibited the phosphorylation level of AKT, mTOR, Smad2/3, and promoted acetylation of histones. Furthermore, the observed inhibitory effect was also confirmed in bleomycin-induced mice lung fibrosis and nude mouse transplanted tumor model. Overall, these data suggest that dual inhibition of HDAC and the tyrosine kinase signaling pathways with CUDC-907 is a promising treatment strategy for TGF?1-induced lung and tumor fibrosis.

SUBMITTER: Zhang W 

PROVIDER: S-EPMC7499263 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dual inhibition of HDAC and tyrosine kinase signaling pathways with CUDC-907 attenuates TGFβ1 induced lung and tumor fibrosis.

Zhang Wentian W   Zhang Yajie Y   Tu Tian T   Schmull Sabastian S   Han Yu Y   Wang Wenbo W   Li Hecheng H  

Cell death & disease 20200917 9


TGFβ1 signaling is a critical driver of collagen accumulation in pulmonary fibrotic diseases and a well-characterized regulator of cancer associated fibroblasts (CAF) activation in lung cancer. Myofibroblasts induced by TGFβ1 and other factors are key players in the pathogenesis of lung fibrosis and tumor. Tremendous attention has been gained to targeting myofibroblasts in order to inhibit the progression of fibrosis and myofibroblast-induced tumor progression and metastasis. Here we determined  ...[more]

Similar Datasets

| S-EPMC6959516 | biostudies-literature
| S-EPMC7568419 | biostudies-literature
| S-EPMC6777681 | biostudies-literature
| S-EPMC5494693 | biostudies-literature
| S-EPMC7479613 | biostudies-literature
2016-11-02 | GSE89339 | GEO
| S-EPMC3903543 | biostudies-literature
| S-EPMC8585736 | biostudies-literature
| S-EPMC6307843 | biostudies-other
| S-EPMC4496203 | biostudies-literature